美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aspire Biopharma Holdings Inc.

0.4530

-0.0341-7.00%

盘后：0.46500.0120+2.65%16:05 EDT

成交量：15.80万

成交额：7.61万

市值：2,215.22万

市盈率：-309.85

高：0.5080

开：0.4900

低：0.4500

收：0.4871

数据加载中...

总览公司新闻公告

公司资料

公司名字：

Aspire Biopharma Holdings Inc.

交易所：

NASDAQ

成立时间：

2021

员工人数：

- -

公司地址：

194 Candelero Drive,Suite 223,Humacao,Puerto Rico,United States

官网：

http://www.aspirebiolabs.com

邮编：

00791

电话：

传真：

- -

简介：

Aspire Biopharma Holdings, Inc.成立于2021年2月9日，是一家特拉华州公司。该公司是一家早期生物制药公司，从事开发和营销新型递送机制颠覆性技术的业务，最初用于“不伤害”药物。迄今为止，Aspire已开发并获得了颠覆性技术，这些技术是一种新型可溶性制剂，旨在解决紧急情况、药物功效、剂量管理和响应时间等问题。Aspire的重点是开发任何数量的可溶性、PH中性、速效粉末或颗粒形式的产品，允许产品的快速舌下吸收。

董事

名称

职位

Bruce Hack

Executive Chairman and Director

Jack Tretton

Chief Executive Officer and Director

Julie Uhrman

Independent Director

Kyle Campbell

Independent Director

Peter Blacklow

Independent Director

股东

名称

职位

Jack Tretton

Chief Executive Officer and Director

Michael Olson

Chief Financial Officer

Bruce Hack

Executive Chairman and Director

Gabriel Schillinger

President

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ASBP/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ASBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASBP\",,,,,undefined,":{"symbol":"ASBP","market":"US","secType":"STK","nameCN":"Aspire Biopharma Holdings Inc.","latestPrice":0.453,"timestamp":1745870400000,"preClose":0.4871,"halted":0,"volume":157969,"hourTrading":{"tag":"盘后","latestPrice":0.465,"preClose":0.453,"latestTime":"16:05 EDT","volume":1,"amount":0.465,"timestamp":1745870709326},"delay":0,"floatShares":31062729,"shares":48901000,"eps":-0.001462,"marketStatus":"盘后交易","change":-0.0341,"latestTime":"04-28 17:31:00 EDT","open":0.49,"high":0.508,"low":0.45,"amount":76089.556176,"amplitude":0.119072,"askPrice":0.5367,"askSize":600,"bidPrice":0.4465,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.001462,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1745884800000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":0.4871,"preHourTrading":{"tag":"盘前","latestPrice":0.483,"preClose":0.4842,"latestTime":"08:00 EDT","volume":66,"amount":31.878,"timestamp":1745841605793},"postHourTrading":{"tag":"盘后","latestPrice":0.465,"preClose":0.453,"latestTime":"16:05 EDT","volume":1,"amount":0.465,"timestamp":1745870709326},"volumeRatio":1.868836},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASBP\",,,,,undefined,":{"symbol":"ASBP","floatShares":31062729,"roa":"--","roe":"--","lyrEps":-0.00081,"volumeRatio":1.868836,"shares":48901000,"dividePrice":0,"high":0.508,"amplitude":0.119072,"preClose":0.4871,"low":0.45,"week52Low":0.4011,"pbRate":"-27.64","week52High":15.8,"institutionHeld":0,"latestPrice":0.453,"committee":-0.714286,"eps":-0.001462,"divideRate":0,"volume":157969,"delay":0,"ttmEps":-0.001462,"open":0.49,"prevYearClose":11.5,"prevWeekClose":0.4871,"prevMonthClose":0.5826,"prevQuarterClose":0.5826,"fiveDayClose":0.495,"twentyDayClose":0.64,"sixtyDayClose":11.8},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1860544308,"yearFounded":2021,"address":"194 Candelero Drive,Suite 223,Humacao,Puerto Rico,United States","zipCode":"00791","officePhone":"415 592 7399"},"stockCompanyDetail":{"websiteUrl":"http://www.aspirebiolabs.com","stockEarnings":[{"period":"1week","weight":-0.1424},{"period":"1month","weight":-0.2389},{"period":"3month","weight":-0.9598},{"period":"6month","weight":-0.9583},{"period":"1year","weight":-0.9563},{"period":"ytd","weight":-0.9576}],"compareEarnings":[{"period":"1week","weight":0.046},{"period":"1month","weight":-0.0316},{"period":"3month","weight":-0.0943},{"period":"6month","weight":-0.049},{"period":"1year","weight":0.0936},{"period":"ytd","weight":-0.0605}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aspire Biopharma Holdings, Inc.成立于2021年2月9日，是一家特拉华州公司。该公司是一家早期生物制药公司，从事开发和营销新型递送机制颠覆性技术的业务，最初用于“不伤害”药物。迄今为止，Aspire已开发并获得了颠覆性技术，这些技术是一种新型可溶性制剂，旨在解决紧急情况、药物功效、剂量管理和响应时间等问题。Aspire的重点是开发任何数量的可溶性、PH中性、速效粉末或颗粒形式的产品，允许产品的快速舌下吸收。","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":0.045588},{"month":2,"riseRate":0.666667,"avgChangeRate":-0.290368},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.201784},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.050078},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.001658},{"month":6,"riseRate":1,"avgChangeRate":0.002239},{"month":7,"riseRate":0.666667,"avgChangeRate":0.003474},{"month":8,"riseRate":0.666667,"avgChangeRate":0.012669},{"month":9,"riseRate":0.666667,"avgChangeRate":0.030139},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.019111},{"month":11,"riseRate":0.666667,"avgChangeRate":0.004225},{"month":12,"riseRate":1,"avgChangeRate":0.002692}],"exchange":"NASDAQ","name":"Aspire Biopharma Holdings Inc.","nameEN":"Aspire Biopharma Holdings Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ASBP\",market:\"US\",,,undefined,":{"directors":[{"name":"Bruce Hack","position":"Executive Chairman and Director"},{"name":"Jack Tretton","position":"Chief Executive Officer and Director"},{"name":"Julie Uhrman","position":"Independent Director"},{"name":"Kyle Campbell","position":"Independent Director"},{"name":"Peter Blacklow","position":"Independent Director"}],"executives":[{"name":"Jack Tretton","position":"Chief Executive Officer and Director"},{"name":"Michael Olson","position":"Chief Financial Officer"},{"name":"Bruce Hack","position":"Executive Chairman and Director"},{"name":"Gabriel Schillinger","position":"President"}]},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ASBP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ASBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ASBP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ASBP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ASBP","date":"2025-04-25","current":-36.428037,"percent":0.894737,"low":-107.647863,"twenty":-53.967461,"median":-44.487272,"eighty":-38.006872,"high":-28.792214,"avg":-46.609012,"sd":13.320157,"marketCap":23611087},"quantilePoints":[{"date":"2025-03-07","current":-61.718107,"twenty":-79.515888,"median":-61.718107,"eighty":-58.474317,"marketCap":40003023},{"date":"2025-03-14","current":-41.62384,"twenty":-63.871064,"median":-57.344015,"eighty":-54.828644,"marketCap":26978783},{"date":"2025-03-21","current":-49.388839,"twenty":-61.718107,"median":-55.259235,"eighty":-45.464716,"marketCap":32011722},{"date":"2025-03-28","current":-47.36506,"twenty":-59.766092,"median":-48.376949,"eighty":-45.613987,"marketCap":30699995},{"date":"2025-04-04","current":-38.75323,"twenty":-56.183571,"median":-46.367595,"eighty":-43.647619,"marketCap":25118177},{"date":"2025-04-11","current":-38.035578,"twenty":-55.34679,"median":-45.929755,"eighty":-40.946376,"marketCap":24653026},{"date":"2025-04-17","current":-39.57853,"twenty":-55.287942,"median":-45.474044,"eighty":-39.546954,"marketCap":25653101},{"date":"2025-04-25","current":-36.428037,"twenty":-53.967461,"median":-44.487272,"eighty":-38.006872,"marketCap":23611087}],"updateTime":1745837797858}}}